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The Effect of Dose, Dose Rate, Route of
Administration, and Species on Tissue and
Blood Levels of Benzene Metabolites
by Rogene F. Henderson,* Patrick J. Sabourin,*
William E. Bechtold,* William C. Griffith,*
Michele A. Medinsky,* Linda S. Birnbaum,t and
George W. Luciert
Studies were completed in F344/N rats and B6C3F, mice to determine the effect ofdose, dose rate, route
ofadministration, and rodent species on formation oftotal and individual benzene metabolites. Oral doses
of50 mg/kg or higher saturated the capacity for benzene metabolism in both rats and mice, resulting in an
increased proportion ofthe administered dose being exhaled as benzene. The saturating air concentration
for benzene metabolism during 6-hr exposures was between 130 and 900 ppm. At the highest exposure con-
centration, rats exhaled approximately halfofthe internal dose retained at the end ofthe 6-hr exposure as
benzene; mice exhaledonly 15% as benzene. Mice were able toconvert more ofthe inhaled benzene to metabo-
lites than were rats. In addition, mice metabolized more ofthe benzene bypathways leading to the putative
toxic metabolites, benzoquinone and muconaldehyde, than did rats. In both rats and mice, the effect ofin-
creasing dose, administered orally or by inhalation, was to increase the proportion ofthe total metabolites
that were the products ofdetoxification pathways relative to the products ofpathways leading to putative
toxic metabolites. This indicates low-affinity, high-capacity pathways for detoxification and high-affinity,
low-capacity pathways leading to putative toxic metabolites. If the results of rodent studies performed at
high doses were used to assess the health risk at low-dose exposures to benzene, the toxicity ofbenzene would
be underestimated.
Introduction
Problem
In the absence ofdose-response data in humans, long-
term rodent studies involving hundreds of animals are
used to predict the carcinogenicity ofcompounds for peo-
ple. However, the responses of rodents to compounds
may vary widely between species, both in the type ofre-
sponse and in the amount of compound eliciting a re-
sponse. Also, for convenience or for economic reasons, ro-
dent studies may not use the same route of exposure or
the same dose rate as that expected in humans. To be
able to interpret these animal data for extrapolation to
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health risk assessments for humans, one must obtain
more information on the basis for the rodent responses.
Important areas to consider are the effect of species,
route ofexposure, and dosingregimen on the disposition
and metabolic fate ofthe administered material. Such in-
formation is critical for determining the biologically ef-
fective dose delivered to target sites in the body under
the different exposure situations. The following is a re-
port ofstudies conducted at the Lovelace Inhalation Tox-
icology Research Institute in collaboration with the Na-
tional Institute of Environmental Health Sciences to
determine the disposition and metabolic fate ofbenzene
in rats and mice under different exposure conditions.
Background
The major concern in chronic exposures ofhumans to
benzene is its adverse hemopoietic effects and neoplas-
tic orpreneoplastic effects in othertissues. The incidence
of leukemia, pancytopenia, and preleukemia in humans
exposed to benzene is significantly higher than in theHENDERSON ET AL.
general population (1). Benzene may also be afactoi in the
development ofother forms ofcancer, such as Hodgkin's
disease, multiple myeloma, and lung cancer (1).
Studies by Maltoni et al. (2,3) and by the National Tox-
icology Program (NTP) (4) clearly show that benzene ad-
ministereed to rodents by gavage or inhalation produces
ineoplasia in a variety of tissues. In the NTP studies
B6C3F i mice and female F344/N rats received 0, 25, 50,
100 mg benzene/kg orally, in corn oil, 5 days/week for 103
weeks. Male F344/N riats received 0, 50, 100, and 200 mg
benzene/kg in the same dosing regimen. Maltoni and co-
workers exposed Sprague-Dawley riats to 200 to 300 ppm
benzene during a2-year period and also conducted an oral
stu(ly in which Sprague-Dawley rats were administered
0, 50, and 250 mgbenzene/kgin olive oil, 5 times/week for
52 weeks and were held for92 weeks for observation. The
tumorigenic riesponses in these studies were species-
(lependlent. Mice developed neoplasms in the lung,
Harderian gland, preputial gland, ovary, mammary
gland, aind liver while rats did not. Benzene induced ne-
oplasms in the Zymbal gland of both riats and mice and
in the oral cavity and skin of rats only. To interpret the
riesults ofsuch animal studies for human risk assessment,
it is important to know the effect of species, rioute ofad-
ministratioin, total inteinal dose, and rate at which the
dose was delivered on the disposition and metabolic fate
of the benzene.
Approach
Two types of studies were conducted to address the
problem (lescribed. First, '4C-benzene was used to deter-
minie the effect ofspecies, exposure dose, and route ofex-
posure on the excretion patterns and total metabolites
formedl from benzene. ("Exposure dose" is used here to
in(licate the amount ofmaterial presented to the animal
by ainy rioute ofexposure, i.e., the amount orally instilled,
the amount injected, IP, or the inhalation exposure con-
centration over a specific time.) Second, the effect ofspe-
cies, exposure dose, exposure dose rate, and the route of
exposure on tissue and blood levels ofindividual metabo-
lites was determined using 3H-benzene. The 3H-benzene
was riequired to obtain a high enough specific activity in
benzene metabolites to be able to detect them in tissues.
Because the individual metabolites were isolated prior to
rcadioactivity determination, there was not a problem
with measuring tritium that was not associated with the
metabolites. Initial studies using both 14C- and 3H-labeled
benzene indicated only a minor (X\10%) isotope effect for
any of the metabolites (7).
Methods
The methods for the conduct of the studies have been
published (5-8). Inhalation exposures were in nose-only
chambers described by Raabe et al. (9). Analysis of
organic-soluble metabolites ofbenzene (7) was performed
oIn ethyl acetate extracts ofsamples to which excess (car-
rier) unlabeled benzene and its metabolites had been
a(lded. Butylated hydroxytoluene was adlde(l as an an-
tioxidlant. The metabolites were separatedl by semi-
preparative reverse-phase high-performance liquid chro-
matography (HPLC). Isolated compounds were analyzed
for radioactivity (by liquid scintillation spectrometry) an(l
for mass (by UV absorption). The total amount of each
compound present was calculated firom the mass dilution
ofthe radiolabeled isotope. An ion-pairing HPLC method
w,as developed to analyze the water-soluble metabolites
(8). Ascorbate was added as an antioxidlant to the water-
soluble fraction oftissue extracts and +D-saccharic acid-
1,4-lactone was addecd to inhibit the breakdown of
glucuronide conjugates. The metabolites were separated
bv reverse-phase HPLC using tetrabutyl ammonium
hydlrogen sulfate as the ion-pairing agent. In calculating
the amount ofboth water-soluble and organic-soluble ben-
zene metabolites, the expected loss of 3H during metab-
olism wAas taken into accouint.
Excretion Routes and Total
Benzene Metabolites Formed
This study has been reported in detail (5). '4C-Benzene
was administered to the species used in the long-term bio-
assay studies (F344/N rats, Sprague-Dawley rats, and
B6C3F1 mice) orally, by IP injection, and by inhalation.
In the inhalation studies, the internal dose retained in the
animals was determined at the end ofthe 6-hr exposure
by liquid scintillation spectroscopy. Routes of excretion
were determined by measuring 14C in urine, feces, and
exhaled air (separating CO2 from benzene) for 48 hr af-
ter dose administration. Total metabolites were deter-
mined by summing the 14C-activity in urine, feces, C02,
and remaining in the carcass. Mass balance between the
administered dose and the total amount excreted or re-
tained in the body was determined and indicated recov-
eries of 100 + 12% (x + SD, n = 19 studies) (5).
By any route ofexposure, over 95% ofthe administered
radioactivity had been excreted in 48 hr, and approxi-
mately 90% ofall metabolites were excreted in the urine.
In both rats and mice, there was an increased amount of
the aclmiinistered dose that was exhaledl as benzene at
(loses of 50 mg/kg or higher (Fig. 1). [There were no
differences in the riesults observedl in the two strains of
rats (5); therefore, the rat data have been combined.] The
same excretion patterns were observed after IP injection
(Fig. 2). Concomitant with the increased amount of ex-
haled benzene at the higher doses, there was a decrease
in the percent of the dose converted to metabolites.
The results from the inhalation study are shown in Ta-
ble 1. The mice receivedl a higher internal dose for the
equivalent exposure conditions than didl the rats. The
mice were also better able to metabolize the inhaled ben-
zene at the higher concentration and exhaled less benzene
after exposure. Why do mice receive a higher internal
dose than rats in the inhalation exposures? Mice have a
higher minute volume per kilogram body weight than
rats (r\- 1.5 x), which would cause the blood concentra-
tions to reach equilibrium more quickly than in rats but
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FIGURE 1. Total metabolites formed from orally administered benzene in F344/N rats and B6C3F, mice during a 48-hr period after dosing. Total
metabolites were calculated as the sum of 14C in urine, feces, exhaled C02, and '4C remaining in carcass at end of 48 hr. The administered
dose, in milligrams per kilogram, is shown at the bottom of each bar. Bars represent the mean SE of values from three animals (5). An asterisk
(*) indicates means that differ from values at doses less than 50 mg/kg, p c 0.05.
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FIGURE 2. Total metabolites formed from IP-administered benzene in F344/N rats and B6C3F1 mice during a 48-hr period after dosing. Total
metabolites were calculated as the sum of 14C in urine, feces, exhaled C02, and '4C remaining in carcass at end of 48 hr. The administered
dose, in milligrams per kilogram, is shown at the bottom of each bar. Bars represent the mean SE of values from three animals (5). An asterisk
(*) indicates means that differ from values at doses less than 50 mg/kg, p s 0.05.
Table 1. Metabolite formation from inhaled benzene.a
% of initial dose
Exposure
concentration, Internal dose, mg/kgb Total metabolites Exhaled benzene
ppm Rats Mice Rats Mice Rats Mice
11 3.3+0.3 7.5+1.1 96+1 99+2 4+0.1 0.1+0.1
130 24 + 2 60 + 6 95 + 1 99 + 1 5 + 0.5 1 + 0.2
930' 117 + 40 152 + 14 52 + 2 86 + 5 48 + 2 14 + 4
aBased on excreta collections over a 48-hr period after a 6-hr exposure. Values are means + SE, n = 3-5.
bBased on '4C-benzene equivalents in body of rodents at end of 6-hr exposure.
'Average of actual exposure concentration for mice (990 ppm) and rats (870 ppm).
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would not affect the steady-state level in blood. The rate
of removal of benzene from the blood would depend on
metabolism, and ahigher rate ofmetabolism inthe mouse
would account for both the high internal dose at all ex-
posure concentrations and the decreased exhalation of
benzene at the highest exposure. In mice, it is possible
to achieve higher internal doses by inhalation thanbythe
oral or IP route (compare Table 1 with Figs. 1 and2). For
example, the highest 6-hr inhalation exposure in mice
resulted in an internal dose at the end ofthe exposure of
152 mg/kg. Ofthis, 86% or 130 mg/kg, was converted to
metabolites. By contrast, oral or IP doses of 150 mg to
mice resulted in only 20 to 30% conversion ofthe dose to
metabolites, with the remainder being exhaled as ben-
zene. Because ofthe rapid exhalation ofthe bolus doses
given IP or orally in mice, only limited internal doses can
be attained by these routes. However, administration of
benzene by inhalation over a 6-hr period allows time for
mice to metabolize the benzene. Thus, when one com-
pares an oral dose to the equivalent dose by inhalation in
terms oftotal metabolites formed(Table 2), one finds that
it is difflcult to achieve as high alevel ofbenzene metabo-
lites in a mouse by a single oral dose as one can achieve
by inhalation.
In summary, this study indicated a)benzene is rapidly
metabolized and excreted, mainly as water-soluble
metabolites in urine, within 40 hrofdosingby any route;
b) bolus doses of50 mg/kg orhigher exceed the ability of
rodents to metabolize benzene and part ofthe dose will
be lostby exhalation ofbenzene; c) mice metabolize ben-
zene more rapidly than rats; and d) benzene administered
at a slow dose rate, as in an extended (e.g., 6 hr) inhala-
tion exposure, will result inhigher internal doses in mice
than bolus dosing. According to these data, almost all the
oral doses given in the long-term bioassay studies
described in the background section of this paper were
beyond the linear range for formation of metabolites in
the rodents. Because the high doses are not converted to
metabolites as efficiently as lower doses, the use of the
Table 2. Extrapolation of oral dose to equivalent 6-hr
inhalation dose.
6-hr
inhalation
exposure, ppm
Total metabolites
formed, mg/kg
Rats Mice
Equivalent single
oral dose, mg/kg
Rats Mice
10 3 10 3 12
25 6 25 6 40
50 12 50 12 150
100 25 80 30
200 40 110 80 -
600 80 150 200 -
aHigher oral doses in mice are mostly exhaled as benzene (Fig. 1);
experimentally, we did not achieve total metabolite levels higher than
50 mg/kg in mice by a single oral dose. According to a mathematical
model based on these data, asingle oral dose ofgreater than 300mg/kg
wvould be required to achieve 80 mg/kg benzene metabolites in mice.
bioassay data to predict the effects of low doses ofben-
zene may underestimate the toxicity of the compound.
Benzene Metabolites
The next part ofour study was to determine the effect
ofspecies and dosingregimen on the amount ofindividual
benzene metabolites in blood and tissues because ourin-
formation on total metabolitesformed did not distinguish
between toxic and nontoxic metabolites. The major meta-
bolic pathways ofbenzene (4) are illustrated in Figure 3.
There are several detoxification pathways. One is the for-
mation ofglutathione conjugates ofbenzene oxide lead-
ing to formation of prephenyl mercapturic and phenyl
mercapturic acid. A second is the formation of
glucuronide or sulfate conjugates of phenol. Two meta-
bolic pathways form putative toxic metabolites,
muconaldehyde (10) and benzoquinone (11). In our ana-
lyses, we have used stable compounds at the end orclose
to the end ofthese pathways as markers for the amount
ofthe benzene being metabolized by the different path-
ways (Table 3). In all blood or tissue samples analyzed,
greater than 90% of metabolites were in water-soluble
forms (Table 4). Therefore, major emphasis was placed
on quantitating the water-soluble benzene metabolites as
indicative ofbenzene metabolism through the majorpath-
ways.
Species Differences in Benzene
Metabolism
This study has been reported in detail previously (6).
F344/N rats and B6C3F1 mice were exposed by inhala-
tion to 50 ppm 3H-benzene for 6 hr. Tissue and blood sam-
ples were analyzed for benzene and its metabolites both
during and for 8 hr after the exposure and the metabo-
lite concentration plotted versus time. The integrated
dose to a tissue over the 14-hr period (6 hr of exposure,
8 hr following exposure) was calculated for each metabo-
lite (area under curve or AUC). The results are shown in
Table 4.
The major metabolic products in rats were detoxifica-
tion products-phenyl conjugates. Hydroquinone and its
conjugates, hydroquinone glucuronide and hydroquinone
sulfate, were either not detectable in rats or present in
trace quantities. On the other hand, mice had substantial
quantities of the markers for the toxification pathways
(muconic acid, hydroquinone glucuronide, and hydroqui-
none sulfate) in tissues in addition to the markers forthe
detoxification pathways. Bone marrow samples taken at
different times were pooled to have sufficient radioac-
tivity for analysis (Fig. 4). The only metabolite detected
in rat bone marrow was phenyl sulfate. In mouse bone
marrow, muconic acid and hydroquinone glucuronide
were also detected. Thus, not only do mice metabolize
benzene faster than rats, mice also form more ofthe puta-
tive toxic metabolites than do rats.
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METABOLIC SCHEME FOR BENZENE
Benzene Oxide HO I
Oxepin
Benzene
PrPh eh nci
Phenyl McrAca.pluric Ml
Mercapturic Acid Benzene Oxide Benzene Glycol
?~~~ ~OH GSH OH_Hi
aS-N-Acetyl-Cy y S-N-Acetyl-C vsa OH
Benzoquinone Hydroquinone Phenol Catechol Trit
C ,kOH )OH 0 OO
Muconic
Acid
0
1
1 IOH
luconaldehyde
0
hydroxy Benzene
Hou0O
..
I I I I
Glucuronide Sulfate Glucuronide Sulfate GI ,curonide Sulfate Glucuronide Sulfate
Fi(;utRiE 3. Metabolism of benzene. Modifiedi from Huff et al. (4).
Table 3. Markers of benzene metabolism.
Pathways Markers
Toxification
Pathway leading to ring breakage Muconic acid
(muconaldehyde)
Pathway leading to benzoquinone Hydroquinone glucuronide or
hydroquinone
Detoxification
Pathway leading to mercapturic Prephenyl mercapturic acid
acid products Phenyl mercapturic acid
Pathways leading to phenyl Phenyl sulfate
conjugates Phenyl glucuronide
Effect of Exposure Dose on
Formation of Benzene Metabolites
This study has been reported in detail elsewhere (12).
F344/N rats and B6C3F1 mice were exposed orally to 1,
10, and 200 mg 3H-benzene/kgbody weight or by inhala-
tion to 5, 50, or 600 ppm 3H-benzene for 6 hr. The highest
oral dose and exposure concentration were expected to
be outside the linear range for total metabolism of ben-
zene as determined by earlier studies. ("Linear range"
refers to a linear relationship between exposure dose and
Table 4. Metabolites formed after a 6-hr inhalation exposure to 50 ppm benzene.a
Rats Mice
Liver Lung Blood Liver Lung Blood
Organic-soluble metabolites
Phenol 0.4 + 0.6 0.2 + 0.3 ND 1.8 + 0.5 2.7 + 0.8 2.6 + 2.0
Catechol 0.03 + 0.14 0.02 + 0.09 ND 5.5 ± 4.0 0.8 + 0.4 ND
Hydroquinone 0.07 ± 0.12 ND 0.3 + 0.3 15 + 3.0 6.1 + 1.5 8.0 + 7.2
Water soluble metabolites
Phenyl sulfate 94 + 29 113 + 15 136 + 26 145 + 29 231 + 37 228 + 49
Phenyl glucuronide ND ND ND 28 + 15 9.9 + 3.3 2.7 + 2.2
Hyclroquinone glucuronide ND ND ND 189 + 27 113 ± 17 105 + 14
Muconic acid 66 + 10 14 + 3 4.6 ± 2.6 1220 + 96 110 + 13 7.9 + 5.3
Phenyl and prephenyl
mercapturic aci(l 36 + 7 4.9 + 1.8 0.9 + 0.7 223 + 31 11 + 2.6 14 + 20
aValues are areas under the curve for metabolite concentrations in the blood and tissue samples over a 14-hr period (6 hr of exposure and 8 hr
following exposure). Values are means + SE in nmole -hr/g, n = 4. ND, not detected; for limits of detection in each tissue, see Bechtold et al. (7)
and Sabourin et al. (8).
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FIGURE 4. Water-soluble benzene metabolites in
samples taken during and for 8 hrfollowing a 6-]
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OS benzene (Fig. 5) was linear with respect to exposure dose
ll s.o 1 ' =zzat 600ppm in mice butnot in rats. (In mice, the curve was
shifted to the right in the 600-ppm exposure, but the
l+ AUC/ppm was not different from that ofthe two lower
z exposure concentrations.) In contrast, the amount ofmu-
conic acid formed was nonlinear after all inhalation ex-
posure concentrations in both species, with proportion-
ally (as percent of the exposure concentration) more
muconic acidformed atthe lower exposure concentration.
If muconic acid is involved in the toxicity from inhaled
benzene, one would underestimate the toxicity of the
compound if one extrapolated from the effects at high
doses in animal studies to expected results at low doses.
Following oral exposures ofrats, the blood concentra-
30 40 tions ofboth phenyl sulfate and muconic acid were non-
linearly related to dose at the highest exposure dose, in-
dicating saturation ofboth pathways of metabolism. In
mice there was asaturation ofthepathwayleadingto mu-
conic acidformationbut atrend toward increased forma-
. Sad) tion of the detoxification metabolite, phenyl sulfate.
In addition, an increasingproportion ofthe inhaled ben-
to zene was converted to glutathione conjugates and to
phenyl glucuronide at the higher exposure concentration
LU in mice (12). Thus, in mice, there appeared to be a shift
toward detoxification pathways at the higher exposure
.J+ dose. Hydroquinone conjugates were barely detectable
z in rats but decreased in proportion relative to the ex-
posure concentration in mice in a manner similar to that
observed for muconic acid. The same trends toward in-
creased formation ofglutathione conjugates and phenyl
glucuronide and decreased formation of hydroquinone
conjugates at the highest dose were noted in orally ex-
posed mice.
30 40 In summary, the effect ofincreasing dose, administered
to rats or mice either orally or by inhalation, was to in-
crease the proportion ofmarkers of detoxification path-
pooled bone marrow ways relative to the markers ofpathways leadingto puta-
hr50-ppm3H-benzene tive toxic metabolites.
exposure Woi. D1one marrow samnpies LKen aTl vanous ulme pOmlIlS were
pooled and processed and analyzed by HPLC as described in
"Methods." The HPLC chromatogram is shown. Numbers above
each peak refer to the nmole metabolite per gram ofbone marrow
tissue. The internal standard wasp-nitrophenyl glucuronide (PNPG).
the amount oftotal benzene metabolites formed.) It was
not known ifthese exposure levels would be outside the
linear range for the amount of individual metabolites
formed. The amount of individual benzene metabolites
formed per unit of exposure was determined in blood and
major tissues. Representative results for a marker ofthe
major detoxification pathway (phenyl sulfate) and a
marker of a toxification pathway (muconic acid) in the
blood are illustrated in Figure 5 for inhaled benzene and
in Figure 6 for orally administered benzene. The graphs
are normalized to the exposure dose (ppm for inhalation;
mg/kg for oral route) and the curves should be superim-
posed on one another if the formation of the metabolite
is linearly related to exposure dose. The amount of the
major metabolite, phenyl sulfate, formed from inhaled
Effect of Exposure Dose Rate on
Metabolic Fate of Benzene
Because previous studies indicated differences between
a bolus dose (given orally) and a dose administered over
6 hr (by inhalation) (5), a study was designed to determine
the effect on benzene metabolism ofextended inhalation
exposures to low concentrations versus short exposures
to high levels (12). Fischer 344/N rats and B6C3F1 mice
were exposedby inhalation to one ofthree exposure regi-
mens, all having the same concentration x time factor:
600 ppm benzene for 0.5 hr, 150 ppm for 2 hr, or 50 ppm
for 6 hr. The AUCs for benzene metabolites in blood and
tissues were determined. If there were no dose rate ef-
fects, the ACUs should be the same for all exposure regi-
mens. In general, there was no dose-rate effect in rats.
In mice, however, the fast exposure rate (0.5 hr x 600
ppm) produced less muconic acid in blood, liver, and lung
(Fig. 7). In the blood and lung, less hydroquinone
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FIGURE 5. Blood metabolites during and after exposure of F344/N rats and B6C3F1 mice to 5, 50, or 600 ppm benzene for 6 hr. The nanomoles
metabolite per gram ofblood has been normalized to the part per million exposure to allow comparison ofthe effect of exposure concentration
on the amount ofmetabolites produced. Ifthe increase in metabolite concentration is linearly related to the increase in exposure concentration,
the curves will be superimposed on each other. Points and bars represent the mean + SE of four values. This illustration is from an earlier
publication (12).
glucuronide was produced at the high exposure rate, and
more prephenyl mercapturic acid was produced at the
two higher dose rates. In the pooled bone marrow sam-
ples (data not shown), there was areduction in the ratios
ofthe markers ofthe toxic benzene metabolic pathways
(muconic acid and hydroquinone glucuronide) to the ma-
jor metabolite (phenyl sulfate) at the highest exposure
rate in mice. These results are similar to what was ob-
served in mice exposed to 600 ppm for 6 hr and confirm
the fact that at high exposure concentrations, mice tend
to shift agreaterportion oftheirbenzene metabolism to-
ward detoxification pathways. In summary, the effect of
increased dose rate in inhalation exposures of mice ap-
pears to be the same as for increased exposure concen-
trations.
Summary
The results of these studies indicate mice metabolize
benzene faster than rats and convert more ofthe benzene
to toxic metabolites that do rats. For both species, in
general, the detoxification pathways for benzene appear
to be low-affinity, high-capacity pathways, whereas path-
ways leading to the putative toxic metabolites appear to
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FIGURE 6. Blood metabolites following an oral exposure of F344/N rats and B6C3FI mice to 1, 10, or 200 mg/kg benzene in corn oil. The nanomoles
metabolite per gram ofblood has been normalized to the dose in milligrams per kilogram to allow comparison ofthe effect of dose on the amount
of metabolite produced. If the increase in metabolite concentration is linearly related to the increase in dose, the curves will be superimposed
on each other. Points and bars represent the mean ± SE of four values. This illustration is from an earlier publication (12).
be high-affinity, low-capacity systems. The net result of
extending exposure dose regimens beyond the range of
linear metabolism rates (above r 200 ppm by inhalation
or \.' 50mg/kgby the oral route) is to reduce the amount
oftoxic metabolites formed relative to the amount ofad-
ministered material. In a risk assessment process, ifthe
results of animal studies performed at high exposure
doses were extrapolated to assess the health risk to hu-
mans exposed to low doses ofbenzene, the toxicity ofben-
zene would be underestimated.
The major objective ofthese studies was to obtain in-
formation to allow better extrapolation ofthe results of
animal studies to expected results in humans. To achieve,
this, the animal data have been used to develop a mathe-
matical model to predict the disposition and metabolic
fate ofbenzene under all exposure conditions in rodents
(13,14). The next step is to alter the physiological
parameters used in this model to fit the known physio-
logical values for humans. The model can also be
strengthenedby making use ofknown values for metab-
olism ofbenzene by human tissues in vitro. Finally, lim-
ited data from humans exposed accidentally to benzene
canbe used to validate the model. With this approach, the
animal toxicokinetic data developed in these studies
should prove useful in improving our ability to assess hu-
man health risks associated with benzene exposures.
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FIGURE 7. The effect of exposure r-ate on lung, liver, and blood metabo-
lites formed in 136CF, mice exposed to benzene by inhalation. The
midce were exposed by the indicated exposure regimens which have the
same concentration times time factor (C x T = 300 ppm/hr'). The tis-
sue or blood metabolite concentrations were determined at regular in-
tervals during and after the exposures and were plotted versus time
after initiation of the exposures. The area under the curve (AUC),
which represents the dose ofthe metabolite received by the tissue, is
shown for each metabolite for each dose rate. Ifthe dose rate does not
influence the tissue metabolite dose, the bar-s(AUCs) wNill be equal for
all dose rates. Values shown are the mean + SE offour samples. PG,
phenyl glucuronide; HQG, hydroquinone glucuronide; PS, phenyl sul-
fate; MU, muconic acid; Pre-PMA, prephenyl mercaptuwic acid; PMA,
phenyl mercapturic acid; HQS, hydroquinone sulfate.
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